streptococcus thermophilus

Condiciones de salud que streptococcus thermophilus puede ayudar a apoyar.

• DislocaciónCientífico

  Clinical trials using VSL#3, which contains S. thermophilus, have shown reductions in abdominal pain and bloating in IBS patients. A separate RCT of S. thermophilus-containing fermented milk also improved global IBS symptom scores including abdominal discomfort. These effects are attributed to improved intestinal barrier function and modulation of gut microbiota.

• HipocondríaCientífico

  S. thermophilus produces exopolysaccharides with documented antioxidant properties, and certain strains harbor genes encoding superoxide dismutase (SOD) antioxidant enzymes. Fermentation of substrates by S. thermophilus has been shown to increase antioxidant activity in food matrices, and in vitro studies confirm antioxidant activity of lactic acid bacteria including S. thermophilus.

• Fatiga SuprarrenalCientífico

  Animal studies using heat-killed S. thermophilus in type 2 diabetic rat models have demonstrated reductions in fasting blood glucose, glucose intolerance, HbA1c, fasting insulin, and HOMA-IR. Human clinical evidence using S. thermophilus specifically for blood sugar is limited, appearing within combination probiotic trials rather than standalone studies.

• Contaminación AmbientalCientífico

  Streptococcus thermophilus was included in the VSL#3 probiotic blend tested in an RCT in celiac disease patients (PMC4972910; 450 billion CFU/day for 12 weeks). S. thermophilus produces lactase, which is directly relevant to the secondary lactose intolerance common in CeD. The PMC 2019 Nutrients review notes S. thermophilus among probiotics that modulate TGF, IL-10, and IL-6 expression relevant to CeD immune pathology.

• Antibióticos (efectos secundarios de los)Científico

  S. thermophilus-containing preparations have been studied in children for acute diarrhea, antibiotic-associated diarrhea, and IBS. A clinical study found S. thermophilus-based preparations reduced diarrhea symptoms by 50% vs. placebo in children. Fermented infant formulas with S. thermophilus showed favorable changes in stool patterns and diarrhea duration.

• AnsiedadCientífico

  S. thermophilus modulates immune gene expression in human immune cells and has been studied in pediatric formulas and probiotic preparations. The VSL#3 preparation containing S. thermophilus has clinical evidence in children with ulcerative colitis, where immune modulation is a key mechanism. Evidence in healthy children's immune function specifically is more limited.

• Válvula IleocecalCientífico

  In vitro studies show S. thermophilus strains can assimilate cholesterol, with one strain (MCC0200) demonstrating 43% cholesterol assimilation in simulated intestinal fluid. Animal data (heat-killed S. thermophilus in diabetic ZDF rats) showed reductions in total cholesterol alongside blood glucose improvements. Human clinical data for cholesterol-lowering specifically from S. thermophilus remain limited.

• ApendicitisCientífico

  S. thermophilus exerts documented immunomodulatory effects, including downregulation of pro-inflammatory cytokines (IL-18, TNF-α, IL-6) and upregulation of anti-inflammatory IL-10, in human peripheral blood mononuclear cell studies and clinical probiotic trials. These mechanisms underpin its studied role in inflammatory conditions.

• ArteriosclerosisCientífico

  Streptococcus thermophilus has been evaluated in combination probiotic products for infantile colic, including a product with B. animalis subsp. lactis BB-12 that reduced caregiver-reported colic incidence. It is part of a multi-strain combination that reduced crying duration by approximately 35 minutes versus placebo. Evidence is from combination probiotic studies rather than standalone trials.

• Estrógeno (bajo)Científico

  S. thermophilus is one of the eight strains in VSL#3, a probiotic preparation with the strongest evidence base for ulcerative colitis, including induction of remission in mild-to-moderate disease in randomized controlled trials. Animal studies with specific S. thermophilus strains also demonstrate delayed colitis onset and improved mucosal barrier function.

• Ojos (rojos o con picazón)Científico

  S. thermophilus, as part of VSL#3, has been studied for preventing post-operative recurrence of Crohn's disease. While direct evidence for S. thermophilus alone in Crohn's is limited, VSL#3 has demonstrated efficacy in this context in controlled trials.

• Vista (deficiente)Científico

  Clinical evidence from randomized and controlled trials supports topical S. thermophilus preparations for atopic dermatitis, improving ceramide levels, skin barrier function, and symptom scores including erythema and pruritus. The mechanism involves bacterial sphingomyelinase activity restoring stratum corneum ceramides.

• Trastornos AutoinmunesCientífico

  Clinical and preclinical evidence supports S. thermophilus in reducing antibiotic-associated diarrhea (AAD) and acute infectious diarrhea. The strain restores microbial balance, upregulates mucosal barrier proteins, and modulates pro-inflammatory cytokines. Studies in children show meaningful reductions in diarrhea duration and severity.

• Retraso del crecimientoCientífico

  Streptococcus thermophilus is a component of the VSL#3 multi-strain probiotic formulation studied in diverticular disease remission maintenance, and is noted for producing anti-inflammatory metabolites and enhancing gut microbiota balance in gastrointestinal disease contexts.

• Parálisis de BellCientífico

  Topical S. thermophilus creams have been tested in clinical trials for atopic dermatitis (eczema), with one controlled study in 11 patients showing increased skin ceramide levels and significant improvement in erythema, scaling, and pruritus. A randomized placebo-controlled trial of inactivated S. thermophilus lotion in 24 patients also showed significant improvement in skin moisture, oiliness, irritation, flaking, and itching.

• Síndrome de DownCientífico

  S. thermophilus produces beta-galactosidase (lactase) that significantly reduces lactose maldigestion, directly addressing lactose sensitivity. Its EPS and immune-modulatory properties have also been studied in atopic contexts. A clinical study in individuals with atopic history consuming S. thermophilus yogurt showed mixed immune parameter results, while its ceramide-restoring topical application showed benefit in atopic dermatitis.

• Leche materna (secar)Científico

  Streptococcus thermophilus is a key yogurt starter culture organism and EFSA Qualified Presumption of Safety (QPS) organism with well-documented effects on gut microbiota, specifically increasing Streptococcus and Lactobacillus in the gut, producing lactase to reduce lactose intolerance symptoms, and modulating mucosal immune responses.

• Senos (aumentar tamaño)Científico

  Streptococcus thermophilus is a dairy probiotic bacterium that has been included in clinical gut-brain axis studies, including a landmark fMRI trial where a fermented milk product containing this strain reduced emotional brain activation. It is identified in the scientific literature as a serotonin precursor producer in the gut microbiome.

• PulgasCientífico

  S. thermophilus has been studied as part of multi-strain probiotic preparations for IBS, with VSL#3 showing superiority over placebo in reducing abdominal pain, discomfort, and bloating in children with IBS in a randomized trial. An RCT also showed that S. thermophilus-containing fermented milk improved global IBS symptom scores and small intestinal permeability.

• FlotadoresCientífico

  S. thermophilus, as part of the VSL#3 probiotic mixture, has demonstrated clinical efficacy in IBD including ulcerative colitis and pouchitis. Evidence also exists from preclinical models showing reduced colitis signs and improved intestinal barrier function. Human clinical evidence for S. thermophilus in Crohn's disease specifically is limited to its role within multi-strain formulations.

• Olor de piesCientífico

  Preclinical evidence from heat-killed S. thermophilus in a type 2 diabetic rat model shows significant reductions in HOMA-IR and fasting insulin levels alongside improved glycemic control. The mechanism proposed involves gut microbiota rebalancing and reduction of systemic inflammatory cytokines that impair insulin signaling.

• CataratasCientífico

  Streptococcus thermophilus is a classical yogurt bacterium that produces β-galactosidase, improving lactose digestion. EFSA approved a health claim for live yogurt cultures (including S. thermophilus) improving lactose digestion based on 14 human intervention studies. A 2023 meta-analysis identifies it as one of the most effective probiotic strains for LI due to highest β-gal activity. The New England Journal of Medicine published foundational evidence establishing its lactase activity.

• Vesícula Biliar (perezosa o extirpada)Científico

  A double-blind, placebo-controlled pilot trial of S. thermophilus ST10 with tara gum in 25 healthy subjects demonstrated significant reductions in intestinal permeability markers (lactulose/mannitol ratio and sucralose) after 30 and 45 days. A separate RCT of S. thermophilus-containing fermented milk also improved small intestinal permeability in IBS patients.

• Resfriados (antiviral)Científico

  A double-blind, randomized, placebo-controlled crossover trial (n=15 resistance-trained men) found that 3 weeks of S. thermophilus FP4 combined with B. breve BR03 (5 billion CFU each) significantly attenuated post-exercise declines in isometric peak torque and range of motion, and reduced circulating IL-6 for up to 48 hours after muscle-damaging eccentric exercise.

• Cabello (pérdida o adelgazamiento)Científico

  Streptococcus thermophilus is listed alongside Lactobacillus and Bifidobacterium strains in evidence-based multi-strain probiotic preparations for PCOS. RCTs using these preparations showed improvements in metabolic and hormonal parameters in PCOS women.

Sistemas corporales que streptococcus thermophilus puede ayudar a apoyar.

• No hay sistemas corporales disponibles.